Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
1992 |
| gptkbp:ATCCode |
G04CB01
|
| gptkbp:brand |
gptkb:finasteride
|
| gptkbp:CASNumber |
98319-26-7
|
| gptkbp:chemicalClass |
5α-reductase inhibitor
|
| gptkbp:contraindication |
pregnancy
|
| gptkbp:eliminationHalfLife |
6-8 hours
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Proscar
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:metabolism |
liver
|
| gptkbp:powers |
5 mg
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
decreased libido
erectile dysfunction ejaculation disorder |
| gptkbp:usedFor |
gptkb:benign_prostatic_hyperplasia
|
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|